Deucravacitinib Shows Significant Efficacy and Safety in Phase 3b/4 Trial for Moderate to Severe Scalp Psoriasis Dermatology Times Source link
The state of dermatology drug development has been accelerating at an unprecedented rate for the last half-decade, with a myriad of targeted and novel therapy breakthroughs achieved in both common chronic diseases—like atopic dermatitis and psoriasis—and previously under-treated and psychosocially-affecting skin disorders—like alopecia areata and vitiligo. Drug options are becoming more robust, more versatile, and […]
TDM-180935 is a small-molecule drug candidate intended to treat atopic dermatitis. Credit: Kaspars Grinvalds / Shutterstock. Chinese biopharmaceutical company Technoderma Medicines has begun dosing patients in its Phase IIa clinical trial of topical TDM-180935 ointment, a potential treatment for atopic dermatitis (AD). The eight-week trial will assess the two different strengths of the topical medication […]
It is that time of year in which your skin feels extra dry and itchy. About 30% of everyone in the United States deals with atopic dermatitis or eczema year-round. News On 6 talked to a local doctor and a research site manager, who are working on a national trial to help treat the chronic […]